Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 29 Apr 2022 |
| Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 24 Apr 2022 |
| Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults | 20 Apr 2022 |
| Bavarian Nordic A/S - Articles of Association | 7 Apr 2022 |
| Resolutions of the Annual General Meeting 2022 of Bavarian Nordic A/S | 5 Apr 2022 |
| New Incentive Programs Established for Members of Executive and Other Management in Bavarian Nordic | 1 Apr 2022 |